SCHEMBL9562394

SCHEMBL9562394

FC(F)(F)c1ccc(CCC2CCNCC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.55
HTR2C P28335 3/20 0.54
SLC6A4 P31645 3/20 0.50
SLC6A2 P23975 2/20 0.50
TAAR1 Q96RJ0 1/20 0.47
HRH3 Q9Y5N1 1/20 0.41
TACR1 P25103 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5749309 0.90 HTR2C (0.51) MAOBHTR2CSLC6A4SLC6A2TAAR1
SCHEMBL894468 0.84 GBA1 (0.59) HTR2CSLC6A4SLC6A2
SCHEMBL3444214 0.83 MAOB (0.49) MAOBHRH3
Hydrochloric Acid SCHEMBL4773715 0.83 GBA1 (0.58) HTR2CSLC6A4SLC6A2
SCHEMBL18892649 0.83 EP300 (0.45) SLC6A4HRH3
SCHEMBL29706740 0.82 MAOB (0.57) MAOBTAAR1
SCHEMBL8307801 0.82 MAOB (0.53) MAOBSLC6A4SLC6A2HRH3TACR1
SCHEMBL9178916 0.81 MAOB (0.56) MAOBSLC6A4SLC6A2TAAR1
SCHEMBL3361925 0.80 TACR1 (0.49) HTR2CSLC6A4SLC6A2TACR1
SCHEMBL1199744 0.79 MAOB (0.53) MAOBSLC6A4SLC6A2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018055096-A1 DISUBTITUTED AZETIDINES, PYRROLIDINES, PIPERIDINES AND AZEPANES AS INHIBITORS OF MONOAMINE OXIDASE B FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES UNIVERSITY OF LJUBLJANA (SI) 2018-03-29 WO disclosed
CN-104876955-A Inhibitors Of Arginase And Their Therapeutic Applications MARS INC 2015-09-02 CN disclosed
CN-103068830-A Arginase inhibitors and therapeutic uses thereof MARS INC 2013-04-24 CN disclosed
EP-0524846-A1 2-(Piperidin-1-yl)ethanol derivatives, their preparation and their use in therapeutics SYNTHELABO (FR) 1993-01-27 EP disclosed